Patients with alcohol use disorder may develop acute ethanol withdrawal syndrome (EWS). Previous studies showed that an epigenetic modification of the N-methyl-d-aspartate (NMDA) receptor, especially NMDA receptor 2B subunit (NR2B), was involved in the pathological process of EWS. However, the relationship between the epigenetic regulation of the NR2B gene in the rat hippocampus region and EWS were inconsistent. The purpose of this study was to explore the role of the histone H3K9 acetylation of the NR2B gene in the rat hippocampus region in EWS. A rat model of chronic ethanol exposure was established. EWS score and the behavioral changes were recorded at different time points. The NR2B expression levels and the histone H3K9 acetylation level in the NR2B gene promoter region were measured using qRT-PCR, Western blot, immunofluorescence, and chromatin immunoprecipitation, respectively. Finally, the relationship between the epigenetic modification of histone H3K9 acetylation of NR2B gene promoter and EWS were examined. Our ultimate results showed that the EWS score was increased at 2 h, peaked at 6 h after withdrawal of ethanol, and reduced to the level parallel to the normal control group at day 3 after ethanol withdrawal. The NR2B mRNA expression and protein levels showed similar patterns. Further correlation analyses indicted that both histone H3K9 acetylation in NR2B gene promoter and the expression levels of NR2B were positively associated with EWS. Our results suggest that chronic ethanol exposure may result in epigenetic modification of histone H3K9 acetylation in NR2B gene promoter in rat hippocampus, and the expression levels of NR2B were found to be positively correlated with ethanol withdrawal syndrome. 
Introduction
Alcohol abuse is one of the major sources of public health problems throughout the world. Continuous consumption of ethanol can lead to the development of dependence and addiction, which may have detrimental effects on brain development [1] . The discontinuation of chronic ethanol exposure is associated with excitatory withdrawal signs and Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s1103 3-019-04733 -7) contains supplementary material, which is available to authorized users.
called ethanol withdrawal syndrome (EWS), which occurs after a sudden cessation of chronic ethanol consumption. Patients withdrawing from ethanol present with autonomic hyperactivity, which may cause the loss of appetite and seizures or evolve into hallucinations, anxiety, hyperexcitability, convulsions and delirium tremens [2] . Up to 25% of hospitalized patients with ethanol use disorder in the United States develop acute EWS [3, 4] . EWS is the most important evidence for the development of physical dependence on ethanol [5] . Although the signs of EWS in humans [6] and rodents [7] have been well described, the mechanisms underlying physical dependence to ethanol and EWS are poorly understood.
Ethanol's primary action on the central nervous system (CNS) is mediated by the disruption of two major neurotransmitter pathways: the inhibitory neurotransmitter γ-aminobutyric acid and the excitatory neurotransmitter glutamate, which binds to the N-methyl-d-aspartate (NMDA) receptor. NMDA receptors appear to be major cell-membrane bound targets for ethanol and may be responsible for mediating its long-term damaging effects [8] . Concurrently, ethanol also inhibits the excitatory action of glutamate at the NMDA receptor, leading to sedative and CNS depressing effects [9] . NMDA receptors, composed of NR1 combined with one or more NR2 (NR2A, NR2B, NR2C, NR2D) subunits and less commonly NR3 subunits [10, 11] , are concentrated at postsynaptic sites [12] . Increasing amounts of evidence is demonstrated the importance of the NR2B subunit in determining the pharmacological and functional properties of the NMDA receptor [13] .
Chronic ethanol exposure leads to tolerance and physical and psychological dependence mediated by the up-regulation of the NMDA receptors [9] . NMDA receptors play a crucial role during chronic ethanol consumption and ethanol withdrawal and central reward systems [14] . During chronic ethanol intoxication, the expression of NMDA receptors and their functions have been found to be up-regulated, possibly due to the depressing and antagonistic effects of ethanol on the NMDA receptors [15] . These mechanisms may initiate neuroadaptive processes, causing the excitatory syndrome upon ethanol withdrawal [15] . Hence, in the study, we attempted to investigate the correlation of ethanol withdrawal syndrome and the expression of the NR2B gene.
The hippocampus is an important part of the brain. It plays a critical role in learning and memory, and is particularly sensitive to ethanol exposure [16] . The hippocampus expresses high levels of NMDA receptors [17, 18] , which are severely impacted by ethanol abuse [19, 20] . Hence, NMDA receptors at the site of the hippocampus region are good candidates for studying excessive ethanol consumption and EWS. A previous study revealed increased numbers of NR2B subunits in the rat hippocampus region after 2 weeks of ethanol vapor exposure [21] . In that study, the site of the interaction between ethanol and NMDA receptors was mainly the NR2B receptor [21] .
There are epigenetic mechanisms involved in various types of neuronal plasticity and behavioral disorders, such as the development of addictive behavior [22] . Modifications of histones have emerged as important mechanisms for the translation of a variety of environmental stimuli (such as the administration of drugs of abuse) into specific changes in gene expression [23] . Even though several reports have indicated that histone modifications are involved in alcohol-related events [24] , it is still unclear how this happens. It has been reported that ethanol exposure produces epigenetic modifications, including histone acetylation and methylation in the hippocampus, striatum, and prefrontal cortex in both adult and adolescent rats [22, 25] . Other studies have shown that histone acetylation has been examined widely and it has been linked to the activation of gene transcription [26] . These epigenetic modifications were also shown to regulate NR2B transcription in primary neuronal cultures [27, 28] . However, the functional role of the histone H3K9 acetylation in NR2B promoter region involved in EWS has yet to be established.
The purpose of these studies was, therefore, to examine the role of the epigenetic modification of the NR2B gene in EWS, and the relationship between the expression of NR2B protein level and EWS in the rat hippocampus region.
Materials and methods

Preparation for the rat model of ethanol exposure
The animal experiment was performed in the Key Psychiatric Laboratory of the Second Affiliated Hospital of Xinxiang Medical University between April 2016 and February 2017. The study was approved by the Ethics Committee of Xinxiang Medical University, Xinxiang City, China. Care of all of the animals was carried out in accordance with the Ethics Committee. All of the experiments included in the present report were replicated using at least two different rat litters.
Forty-eight male Wistar rats weighing 180-220 g were provided by the Beijing Vital River Laboratory Animal Technology Co., Ltd., China (license No: SCXK Jing 2012-0001). All of the rats were group-housed with free access to water and food in the vivarium, which had a 12-h light/dark cycle and a temperature-regulated environment. The 40 rats in ethanol withdrawal groups were administered with drinking the concentration of 6% ethanol-containing liquid (v/v) for 16 weeks, while rats in normal control group (NC, 8 rats) were maintained with water for 16 weeks.
The scores of ethanol withdrawal syndrome (EWS)
At the end of 6% ethanol-containing liquid diet administration, ethanol was withdrawn from the diet by replacing the diet without ethanol. The 40 ethanol-exposure rats were assigned into 5 different time point groups at random (n = 8 for each group). According to a previous report [29] and a revised evaluation standard of EWS (Supplemental Table 1 ), the EWS was tested and scored at 2 h, 6 h, 1 h, day 1, and day 3 after ethanol withdrawal, respectively.
Preparation for tissue samples
At the end of each withdrawal time point, all of the animals were killed after anesthesia with an injection of chloral hydrate after the behavioral features of EWS were recorded. The hippocampus was removed from the brain and quickly frozen in liquid nitrogen for further experiments.
Western blot for NR2B protein and qRT-PCR for NR2B mRNA
Hippocampus tissues were extracted and total proteins were used for Western blot as previously described [30] . Equal amounts of protein samples (50 µg) were subjected to SDS-PAGE gel, electrophoresed, and transferred to a polyvinylidene fluoride membrane (PVDF). PVDF were then blocked with 10% milk for 2 h at room temperature, followed by incubation overnight at 4 °C with the primary antibodies: anti-NR2B (rabitt polyclonal, Abcam), and anti-GAPDH (rabitt polyclonal, Sigma) which was used as a loading control. PVDF were incubated with goat anti-rabbit secondary antibody (Santa Cruz Biotechnology) for 2 h at room temperature before washing three times for 10 min with PBS. The immune-reactive bands were visualized with the ECL Plus Western Blotting Detection System (Pierce, Rockford, IL, US), and band intensity quantified using Quantity One software (Bio-Rad, Hercules, CA, US). Protein levels were expressed with normalization of NR2B against GAPDH.
Total RNA of the hippocampus tissues was extracted using Trizol Reagent (Invitrogen) according to the manufacturer's instructions. The RT-PCR for NR2B mRNA were performed with a QuantiFast SYBR green qRT-PCR kit (Qiagen, Düsseldsorf, Germany) and reaction conditions were carried out according to the manufacturer's instructions (Applied Biosystems, Foster City, CA, US). GAPDH expression served as an endogenous control to normalize the data. The primer sequence of NR2B gene and GAPDH served as endogenous controls. They are listed in Supplemental Table 2 . Relative quantitative standard curve for NR2B and GAPDH was respectively established with relative copy number as horizontal axis and Ct value as vertical axis, and then calculated the expression quantity of NR2B and GAPDH respectively according to the standard curve. The ratio of the expression quantity NR2B to the expression quantity GAPDH was used as the relative expression of NR2B mRNA for statistical analysis. All of the quantifications were performed with an ABI Prism 7500 system (Applied Biosystems).
Immunofluorescence assay for NR2B protein of rat hippocampus
For NR2B immunofluorescence, paraffin sections were placed in an oven at 60 °C for 30 min. The sections were then deparaffinized and rehydrated by xylene twice and gradient ethanol from pure to 70%. Heat-induced retrieval of antigen was performing using 10 mM sodium citrate (pH 6.0), 3% hydrogen peroxide for 10 min to suppress the endogenous peroxidase activity, and 1% bovine serum albumin (all from Sigma, St. Louis, MO, US) for 15 min to block nonspecific binding. After this, the sections were incubated in rabbit polyclonal NR2B antibody overnight at 4 °C. After washing three times in PBS, 10 min each time, the sections were incubated with goat FITC-labeled fluorescent antibody (1:400) without light at room temperature for 2 h. Nuclei were stained with 4′, 6-diamidino-2-phenylindole (DAPI) without light at room temperature for 10 min. Four random fields in each group were observed under a Leica TCS-SL confocal microscope. The fluorescence intensity was quantified with Image J software (NIH).
Chromatin immunoprecipitation (ChIP) for hippocampal NR2B gene promoter
The ChIP procedure was performed using the instructions provided with the ChIP kit (Millipore, Bedford, MA, US). Briefly, the hippocampus tissue was chopped into small pieces about 1-3 mm 3 using razor blades and then cold PBS and protease inhibitor were added into the broken hippocampal tissue. The broken hippocampal tissue samples were cross-linked with final concentration 1% formaldehyde at room temperature for 15 min, and then 0.25 M glycine was added to stop the fixation. The tissue fragment was treated with protease inhibitor Cocktail II and the hippocampal neurons were isolated using Medimachine system (Becton Dickinson, US) according to the instructions. The cell pellets were then lysed by cell lysis buffer (5 mM PIPES pH8.0, 0.85 mM KCl, and 0.5%NP40) and Nuclear Lysis Buffer (50 mM Tris, pH 8.1, 10 mM EDTA, 0.75%SDS, and 50 mM PMSF). The nuclei were collected and subjected to shearing by sonication. After sonication in lysis buffer, an aliquot of the chromatin was reverse cross-linked to evaluate fragment size and DNA concentration. The sizes of the majority of sonicated genomic DNA ranged from 300 to 600 bp, 1 3 which was appropriate. The samples were divided into three groups: input, immunoprecipitation and negative control. The following steps were operated according to the ChIP kit (Millipore, Bedford, MA, US). Equal amounts of the soluble chromatin from each sample were subjected to immunoprecipitation with anti-acetylated histone H3 at Lys9 (ac-H3K9) antibody (rabitt polyclonal, Abcam,) or IgG (Santa Cruz Biotechnology) as the negative control. The complexes were drawn off with protein G magnetic beads and washed sequentially with wash buffer provide with the kit. The cross-link was reversed and the DNA fragments were then purified with a DNA extraction kit (Qiagen). We designed the special primers of NR2B gene promoter region to amplify, GAPDH as the internal control (sequences listed in Supplements Table 3 ) and the immunoprecipitated DNA, input DNA and negative control DNA served as templates for RT-PCR. The levels of histone acetylation in the promoter area of the NR2B gene were determined by the fold enrichment. The fold enrichment was calculated relative to the percentage of input DNA.
Statistical analysis
All of the data were shown as mean ± SEM and were analyzed utilizing SPSS 15.0 statistical software (SPSS, Chicago, IL, US). One-way analysis of variance (ANOVA) was used to make the comparisons between different ethanol withdrawal groups and normal control group. Pearson's correlation test of the five groups of alcohol abstinence groups was used to assess the relationships between EWS scores, the expression level of NR2B protein, the mRNA expression of NR2B gene and the histone H3K9 acetylation of NR2B gene in hippocampus region. Statistical significance was set to p < 0.05.
Results
Rat model of ethanol exposure
The average amount of 6% ethanol solution consumed everyday was 155.93 ml/kg body weight, which was equivalent to the intake of pure ethanol 7.39 g/kg body weight. There were no significant differences in ethanol consumption (g/kg body weight) at every week and weeks of drinking (p > 0.05) (Supplemental Fig. 1a) . After a 16-week treatment, there were no significant differences in body weight between 5 ethanol consumption groups and the normal control (p > 0.05), suggesting that low concentration of ethanol (6% in our current study) had no significant influence on body weight (Supplemental Fig. 1b) .
Evaluation of ethanol withdrawal syndrome in rats
During the ethanol drinking period, all rats were more docile and less aggressive. After the ethanol was withdrawn, the rats showed increased grooming, sneezing, irritability, tail stiffness, bowing of the back, and auditory epileptic seizures.
Based on different withdrawal time points, the EWS scores were 10.42 ± 2.50 for 2 h, 15.42 ± 1.93 for 6 h, 9.25 ± 2.01 for 12 h, 7.67 ± 1.92 for day 1, and 2.25 ± 0.87 for day 3 ( Table 1 ). All of these EWS scores were significantly higher than those of the normal control group (1.50 ± 0.80; all p < 0.05). At 6 h, the EWS score was highest, and then decreased gradually to the level parallel to NC group (Fig. 1) .
Expression of NR2B protein in hippocampus at different withdrawal time points
The total protein and total RNA from rat hippocampus were extracted separately. The relative expression of the Based on the previous report and a revised evaluation standard in Material and Methods, the EWS scores were counted including stereotyped behavior, irritability tail, stiffness, postural malalignments, and audiogenic seizure at 0 h, 2 h, 6 h, 1 h, day 1, and day 3 after ethanol withdrawal, respectively NR2B mRNA was 0.33 ± 0.046 for 2 h, 0.242 ± 0.059 for 6 h, 0.202 ± 0.044 for 12 h, 0.179 ± 0.039 for day 1, and 0.154 ± 0.022 for day 3, which were all significantly higher than that in normal control group (0.13 ± 0.022; all p < 0.05). The expression of NR2B mRNA peaked at 2 h after withdrawal and the amount of expression began to decrease at the subsequent time points (Fig. 2a) .
With the Western blot assay, the level of NR2B protein was examined at different withdrawal time point. The ratio of NR2B gray level to GAPDH gray level represented the relative level of NR2B protein, and this level was 2.201 ± 0.375 for 2 h, 1.535 ± 0.137 for 6 h, 1.117 ± 0.149 for 12 h, 0.677 ± 0.054 for day 1, and 0.53 ± 0.113 for day 3, which were all significantly higher than that in normal control group (0.481 ± 0.085; all p < 0.05), except for that at day 3 (p > 0.05) (Fig. 2b) . The protein level of NR2B peaked at 2 h after withdrawal and had decreased to normal levels at day 3 (Fig. 2c) .
Immunofluorescence assay for the NR2B protein in rat hippocampus
The level of NR2B protein in the tissues was assayed using an immunofluorescence assay. The nuclei were stained with DAPI (blue) and NR2B protein were stained with secondary antibody labeled with green. The ratio of green to blue of the fluorescence intensity was used as the relative expression of NR2B protein for statistical analysis. Figure 3a shows that the protein level of NR2B peaked at 2 h after withdrawal and had decreased to the level of normal control group at day 3. The NR2B protein level by the immunofluorescence intensity displayed the same pattern as that by Western blot assay, with 1411.36 ± 210.72 for 2 h, 987.38 ± 104.32 for 6 h, 823.62 ± 48.14 for 12 h, 554.71 ± 73.13 for day 1, and 437.24 ± 123.76 for day 3, which were all significantly higher than that in the normal control group (378.56 ± 67.65; all p < 0.05), except for that at day 3 (p > 0.05) (Fig. 3b) . Fig. 1 Evaluation of ethanol withdrawal syndrome in rats after removal of ethanol. The ethanol withdrawal syndrome (EWS) scores were counted at the different time points after ethanol withdrawal. Data are expressed as mean ± SEM (n = 8 rats per group). *Comparisons to the normal control (NC) group; *p < 0.05, ***p < 0.001 Fig. 2 The expression levels of NR2B gene in rat hippocampus at different time points after ethanol withdrawal. a Relative mRNA of NR2B expression at 2 h, 6 h, 12 h, 1 day, and 3 day after ethanol withdrawal were assayed through qRT-PCR, compared with normal control group. Data are expressed as mean ± SEM (n = 8 rats per group). b The expression levels of the NR2B protein in rat hippocampus region were assayed by the Western blot at different points in time after ethanol withdrawal. Data are expressed as mean ± SEM (n = 8 rats per group). c The relative expression levels of the NR2B protein were presented in the form of a histogram at different time points after ethanol withdrawal by gray scale analysis. *Comparisons to the normal control (NC) group; *p < 0.05, ***p < 0.001
H3K9 levels of NR2B gene in hippocampus at different withdrawal time points
The levels of histone H3K9 acetylation of NR2B promoter region in the hippocampus were measured by CHIP. According to the experimental instructions, the fold enrichment of relative acetylation represents the percent of the H3K9 acetylation of NR2B gene at the time point of ethanol withdrawal to at the input. Figure 4 showed that the fold enrichment of histone H3K9 acetylation of NR2B gene to input was 133.38 ± 6.947, 121.85 ± 3.643, 123.0 ± 6.053, 122.21 ± 5.661, and 93.20 ± 3.133 after the ethanol withdrawal at 2 h, 6 h, 12 h, day 1, and day 3, respectively, while the fold enrichment to input was 123.19 ± 5.107 for the normal control group. In this way, the histone H3K9 acetylation of NR2B gene at 2 h after ethanol withdrawal was significantly higher than in the normal control group (p < 0.001), while the fold enrichment of NR2B gene acetylation gradually decreased, showing significant differences at points in time (all p < 0.05) except day 3 (Fig. 4) . Fig. 3 Expression of NR2B protein in rat hippocampus at different withdrawal time points as indicated by immunofluorescence assay. a NR2B expression in hippocampus region at 2 h, 6 h, 12 h, 1 day, and 3 day after ethanol withdrawal was assessed by the immunofluorescence assay. The nuclei were indicated by DAPI staining (blue) and NR2B protein was stained by fluorescent antibody (green pointed by red arrow). Scale bars: 30 µm. Data are expressed as mean ± SEM. b The NR2B immunofluorescence intensity at 2 h, 6 h, 12 h, 1 day, and 3 day after ethanol withdrawal were represented by histogram, comparing with normal control group. *Comparisons to the normal control (NC) group; *p < 0.05, ***p < 0.001 Fig. 4 H3K9 levels of NR2B gene in rat hippocampus at different time points after ethanol withdrawal using Chromatin immunoprecipitation. The level of histone H3K9 acetylation of NR2B gene promoter in rat hippocampus region at 2 h, 6 h, 12 h, 1 day, and 3 day after ethanol withdrawal was assessed using chromatin immunoprecipitation. Data are expressed as mean ± SEM (n = 8 rats per group). *Comparisons to the normal control (NC) group; *p < 0.05, ***p < 0.001
Correlation between the EWS score, the levels of H3K9 acetylation of NR2B gene promoter and the expression of NR2B in rat hippocampus Correlation analysis showed the expression levels of the hippocampus NR2B protein to be positively correlated with the EWS scores (r = 0.522, df = 40, p = 0.0006) (Fig. 5a) . Similarly, there was a significant positive correlation between the expression of NR2B mRNA and the level of NR2B protein (r = 0.7754, df = 40, p < 0.0001) (Fig. 5b) . These results suggested a close relationship between EWS and the expression of NR2B mRNA and protein.
Subsequent correlation analysis showed that levels of histone H3K9 acetylation in NR2B promoter region to be positively correlated with both the expression of NR2B mRNA (r = 0.6642, df = 40, p < 0.0001) (Fig. 5c ) and the EWS scores (r = 0.4787, df = 40, p = 0.0018) (Fig. 5d) .
Discussion
EWS consists of a variety of behavioral symptoms, physiological signs, and the electrophysiological changes in the central nervous system [6] . NMDA receptor is an ionotropic receptor that is involved in synaptic plasticity and memory formation, which is the main target of ethanol in the CNS [31, 32] . Although the effects of ethanol on the NMDA receptor are unclear, it has been found that the effects of ethanol on the CNS are related to the NMDA receptor subunits, especially NR2B [33] . The hippocampus is an important region in the brain and it is also rich in NR2B subunits. Previous studies showed that many neurological symptoms caused by ethanol, such as ethanol withdrawal symptoms and nerve excitotoxicity, are closely related to the NR2B subunit [33] . For example, a previous study reported that the expression level of the NR2B protein was significantly higher in cultured hippocampus and cortical primary neurons of rats after chronic ethanol treatment, while NR2A, NR2C and NR2D did not change significantly [21] . Also, in an animal experiment performed in rats, the level of the NR2B mRNA was significantly higher after 2 weeks of chronic ethanol treatment [34] . Our results indicated that the NR2B protein level were higher 2 h after ethanol withdrawal. Taken together, these findings suggest that the expression level of the NR2B protein in hippocampus may be involved in ethanol abuse/dependence and withdrawal behaviors.
The process of ethanol withdrawal or chronic intermittent ethanol (CIE) has been shown to increase subsequent ethanol consumption in mice [35] . However, the mechanisms underlying the motivation to drink during ethanol withdrawal are not fully understood. Previous studies showed that CIE caused DNA demethylation and increased histone acetylation in the promoter region of the NR2B gene [27] . In the hippocampal region of adult male Wistar rats, NR2B levels were significantly higher after chronic ethanol exposure [36] . Our present study showed that the expression level of the NR2B protein had a significant correlation with the scores of EWS. Moreover, there was a notable correlation between the relative mRNA expression of NR2B and the level of the NR2B protein. Here, we speculate that there was correlation between EWS and the relative expression of NR2B mRNA.
Histone acetylation includes acetylation of H3 and H4. H3K9 is the only residue that can be acetylated or methylated, but not both at the same time [37] . Histone H3K9 acetylation was found to be "inversely correlated" with H3K9 methylation [38] . A previous study found that acute ethanol use induced the significantly increased histone H3K9 acetylation, with fewer changes in K14, K18, and K23 acetylation status [39] . One recent study found that chronic intermittent ethanol exposure and ethanol withdrawal increased the expression of NR2B and the acetylation level of H3K9 in cultured mouse cortical neurons [27] . Taken together, these results suggest that ethanol may selectively produce the effects on the histone H3K9 as the target.
There are several limitations in this study. First, the role of epigenetic modification of NR2B gene promoter in ethanol withdrawal syndrome was examined solely in the hippocampus. Whether such a relationship exists in other parts of the brain merits further investigation. Second, more behavioral experiments, such as the CPP experiment and Morris water maze test are needed to observe the relationships between ethanol withdrawal and behavioral characteristics. Third, we will consider three groups of experiments including regular diet group, Ethanol group and Ethanol-withdrawal group in the following relevant experiments. Finally, the underlying mechanisms that EWS caused in histone acetylation of NR2B is still unclear, it will need to be examined in further research.
In summary, after a rat model of chronic ethanol exposure and EWS was established, we speculate that, at the time of EWS, the histone H3K9 acetylation of the NR2B gene promoter regions may affect the transcription of the NR2B gene and then regulate the level of the NR2B protein. And, all of those suggest the epigenetic modification of histone H3K9 acetylation in the NR2B gene and the expression level of the NR2B protein are likely to be one of the important regulatory mechanisms underlying EWS. Taken together, it is reasonable to speculate that ethanol withdrawal may lead to increased levels of histone H3K9 acetylation of the NR2B gene and the NR2B protein expression in the hippocampus region, which may play an important role in the development of EWS.
